IQVIA SmartSolve®: The AI Quality Breakthrough Life Sciences Leaders Didn’t See Coming

Overview: How IQVIA SmartSolve's AI-Driven eQMS Platform is Transforming Life Sciences

IQVIA SmartSolve® is an AI‑enabled electronic quality management system (eQMS) that unifies quality and regulatory processes for life sciences organisations on a single cloud platform. It centralises document control, CAPA, risk, and quality event management, and embeds connected analytics across the product lifecycle to address fragmented, manual workflows. Built on Microsoft Azure and IQVIA’s connected intelligence stack, SmartSolve uses machine learning, regulatory intelligence, and post‑market surveillance data to highlight emerging issues, support closed‑loop investigations, and surface trends that would be hard to see in siloed systems.

In this directory, eQMS tools are assessed on whether risk information simply documents issues after they occur or actively drives CAPA, change control, complaints and management review from a central risk model.

For operational and quality teams, this architecture reduces time spent reconciling data across systems and helps standardise responses to deviations, inspections, and interactions with health authorities. Preconfigured workflows, electronic signatures, audit trails, and role‑based dashboards help shorten approval cycles and make it easier to maintain audit‑ready records, reducing administrative burden and supporting more consistent, evidence‑based decisions on product quality and patient safety.

What is IQVIA SmartSolve®?

IQVIA SmartSolve® is an AI-enabled electronic quality management system (eQMS) that centralises quality, regulatory, and post‑market processes for life sciences organisations, covering areas such as CAPA, deviations, audits, document control, and training management. It is primarily used by pharmaceutical, MedTech, and in vitro diagnostic companies that need a unified platform to manage enterprise‑wide quality events and regulatory information across the product lifecycle. Built on Microsoft Azure with integrated regulatory intelligence, real‑world data signals, and configurable workflows, SmartSolve® differentiates itself by combining eQMS and RIM capabilities into one cloud environment that supports AI-driven analytics, inspection‑ready compliance, and global scale.

Why Leading Healthcare Teams Trust IQVIA SmartSolve®

• SmartSolve® is delivered on a compliance-ready platform based on ISO 9001 standards and is described as supporting the life sciences industry’s most stringent regulatory requirements.

• The platform is associated with ISO 27001 and ISO 9001 certifications within IQVIA’s Quality Management and Regulatory Suite, signalling independent assessment of information security and quality management controls.

• SmartSolve® is explicitly positioned to help organisations meet FDA, EU MDR, and ISO 13485 requirements by providing tools for quality, regulatory, and supplier process management.

• IQVIA documents how SmartSolve® supports compliance with 21 CFR Part 11 for electronic records and electronic signatures, aligning its architecture and controls with FDA expectations for regulated life sciences environments.

• The software includes electronic signatures, audit trails, validation packs, and electronic reporting, which are key features for maintaining inspection‑ready auditability in GxP contexts.

• SmartSolve® RIM extends the platform to manage regulatory submissions, registrations, and health authority interactions, indicating a focus on end‑to‑end regulatory lifecycle support rather than isolated quality modules.

• IQVIA highlights SmartSolve® as part of its award‑winning, end‑to‑end quality management system portfolio, implying external recognition of the broader suite’s ability to address complex regulatory demands.

• Listing on the Microsoft commercial marketplace as a SaaS solution and operation on Microsoft Azure provides additional ecosystem vetting, including underlying cloud security and compliance frameworks recognised by healthcare and life sciences buyers.